Cite
The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells
MLA
Grazia Ambrosini, et al. “The Phosphoinositide 3-Kinase α Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells.” Molecular Cancer Therapeutics, vol. 13, no. 5, Feb. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b44258bd58c6f4a6d2efb43c0b47a07&authtype=sso&custid=ns315887.
APA
Grazia Ambrosini, Elisa de Stanchina, Elgilda Musi, & Gary K. Schwartz. (2014). The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells. Molecular Cancer Therapeutics, 13(5).
Chicago
Grazia Ambrosini, Elisa de Stanchina, Elgilda Musi, and Gary K. Schwartz. 2014. “The Phosphoinositide 3-Kinase α Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells.” Molecular Cancer Therapeutics 13 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b44258bd58c6f4a6d2efb43c0b47a07&authtype=sso&custid=ns315887.